The OIG has created a central listing of quality of care” corporate integrity agreements (CIAs) that providers have entered into as a part of False Claims Act settlements resolving allegations of fraud that impact the quality of patient care. The OIG requires that providers under a quality of care CIA retain an independent quality monitor to attend to the specific issues underlying the allegations as well as to examine and evaluate the provider's ability to address patient care problems. The OIG cautions that the presence of a quality-of-care CIA and a quality monitor is not an admission that the provider provided substandard care, nor is it determinative of the quality of care at the provider's facility.